Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells

For metastatic bladder cancer patients, systemic cisplatin (CDDP)-based combination chemotherapy is the first-line choice of treatment. Although up to 70% of advanced bladder cancer patients initially show good tumor response to this form of combination chemotherapy, over 90% of good responders rela...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Cancer
Asıl Yazarlar: Tatokoro, Manabu, Koga, Fumitaka, Yoshida, Soichiro, Kawakami, Satoru, Fujii, Yasuhisa, Neckers, Len, Kihara, Kazunori
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7447157/
https://ncbi.nlm.nih.gov/pubmed/21964864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.26475
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller